Market revenue in 2023 | USD 0.3 million |
Market revenue in 2030 | USD 0.4 million |
Growth rate | 2.7% (CAGR from 2023 to 2030) |
Largest segment | Veno-arterial |
Fastest growing segment | Veno-Arterial |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Veno-Arterial, Veno-Venous, Arterio-Venous |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Edwards Lifesciences Corp, Getinge AB ADR, Fresenius Medical Care AG, BD, Nipro Corp, Andocor, Surgical Holdings |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to arterial cannula market will help companies and investors design strategic landscapes.
Veno-arterial was the largest segment with a revenue share of 33.33% in 2023. Horizon Databook has segmented the UAE arterial cannula market based on veno-arterial, veno-venous, arterio-venous covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE arterial cannula market , including forecasts for subscribers. This country databook contains high-level insights into UAE arterial cannula market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account